
ICO: Long-Term Safety Data On XALATAN® Presented
PEAPACK, NJ — May 1, 2002 — Data presented for the first time at the XXIXth International
PEAPACK, NJ — May 1, 2002 — Data presented for the first time at the XXIXth International
NEW YORK (Reuters Health) Apr 29 – Treatment with eye drops containing 5-fluorocytosine (5-FC) and cytosine deaminase,
NEW YORK (Reuters Health) Apr 29 – Translocation of the retina appears to be a promising therapeutic
Laurie Barclay, MD NEW YORK (MedscapeWire) Apr 26 The antisense oligonucleotide fomivirsen is reasonably safe and
NEW YORK (Reuters Health) Apr 22 – Granulocyte colony-stimulating factor therapy in patients with AIDS-related cytomegalovirus (CMV)
Journal of Glaucoma 04/26/2002 By Mark Moran Brimonidine-purite 0.15% and 0.2%, appears to decrease intraocular pressure comparably
PEAPACK, NJ — April 23, 2002 — Pharmacia Corporation announced today that the company has successfully completed
New England Journal of Medicine (NEJM) 04/11/2002 By Anne MacLennan Oral valganciclovir appears to be as effective
DENVER (Reuters Health) Apr 18 – Implantation of human retinal cells in the brains of patients with
NEW YORK (Reuters Health) Apr 17 – The US Food and Drug Administration (FDA) has approved conductive
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות